Report
EUR 13.96 For Business Accounts Only

CIGNA with less fundamental stars is reduced to Neutral

CIGNA (US), a company active in the Health Care Providers industry, loses a star(s) at the fundamental level and sees its general evaluation downgraded. The independent financial analyst theScreener just removed a fundamental star(s) for a 3 over 4-star rating. As such, market behaviour remains unchanged and is evaluated as moderately risky. theScreener believes that the loss of a star(s) merits downgrade to the general evaluation of the title, which passes to Neutral. As of the analysis date February 4, 2022, the closing price was USD 221.37 and its expected value was estimated at USD 227.97.
Underlying
Cigna Corporation

Cigna is a global health service organization. The company's segments are: Integrated Medical, which includes its employer-sponsored medical coverage and Medicare offerings for seniors and individual insurance offerings to non-seniors both on and off the public health insurance exchanges; Health Services, which consists of the pharmacy benefit management and certain health management services; International Markets, which provides a range of medical and supplemental health, life, and accident benefits to individuals and employers; and Group Disability and Other, which includes its commercial long- and short-term disability products, and its term life group insurance products.

Provider
TheScreener
TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals.  Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

  • Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization.  theScreener state of art: We provide
  • theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
  • For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded

 

Other Reports on these Companies
Other Reports from TheScreener

ResearchPool Subscriptions

Get the most out of your insights

Get in touch